The case for public funding and public oversight of clinical trials

Economists' Voice

Volumn 4, Issue 1, 2007, Pages 1-4

  Lewis, Tracy R ^a   Reichman, Jerome H ^b   So, Anthony D ^b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33846533611     PISSN: 15533832     EISSN: 15533832     Source Type: Journal    
DOI: 10.2202/1553-3832.1123     Document Type: Article

References (8)

1. See "AMA Recommends that DHHS Establish a Registry for All US Clinical Trials," AMA Press Release, 15 June 2004, available at: http://www.ama-assn.org/ama/pub/category/13934.html
2. "Leading Medical Groups Endorse Public Clinical Trials Registry," American Academy of Child and Adolescent Psychiatry and American Psychiatric Association News Advisory, 9 September 2004, available at: http://www.aacap.org/page.ww?section= 2004+Press+Releases&name=Leading+Medical+Groups+Endorse+Public+ Clinical+Trials+Registry.
3. See also "Reps. Waxman, Markey Introduce Legislation to Establish Mandatory Online Database of Clinical Trials," MediLexicon, 7 July 2005, available at: http://www.medicalnewstoday.com/ medicalnews.php?newsid=27062
4. "Medical Journals to Require Clinical Trial Registration," NewScientist.com news service, 9 September 2004, available at: http://www.newscientist.com/article.ns?id=dn6378.
5. See "Spitzer Sues a Drug Maker, Saying It Hid Negative Data," New York Times, 3 June 2004, p. A-1;
6. Peter Juni et al., "Withholding Research Results in Academic Life Science: Evidence from a National Survey of Faculty," JAMA, 16 April 1997, 277(15): 1224-28 (noting efforts to slow dissemination of undesired results).
7. On the increasing costs of clinical trials, see Henry Grabowski, Joseph DiMasi and John Vernon, "R&D Costs and Returns by Therapeutic Category," Drug Information Journal, 2004, 38(3): 211-23.
8. To read more about this, see the NIH resource information on clinical trials at http://www.nlm.nih.gov/services/ctphases.html.